What this study is
This clinical trial assesses whether resource identification for primary caregivers can affect financial stress, quality of life, depression, and the general belief in the ability to cope with daily life. Caregivers of patients receiving cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CS+HIPEC) demonstrate that they endure high depressive symptom burdens and financial distress. Further, they experience symptom trajectories that differ from those of patients. In short, they require differential timing of supportive interventions. This study aims to reduce financial toxicity and distress levels and to increase self-efficacy, satisfaction and engagement with care. Information gathered from this study may help researchers determine whether telehealth interventions for caregivers may increase awareness of recommended resources that could be beneficial during caregivers journey.
What's being tested
- Telemedicine
Intervention · OTHER
Receive telehealth navigation intervention
- Survey administration
Intervention · OTHER
- Electronic health record review
Intervention · OTHER
- Best Practice
Intervention · OTHER
Receive standard caregiving experience
Both Survey administration and Electronic health record review
Ancillary studies
Study details
- Official title
- Telehealth Intervention to Address Distress and Financial Toxicity in the Care Partners of Patients Receiving Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
- Sponsor
- Wake Forest University Health Sciences
- Conditions
- Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm
- Enrolling
- 50 people
- Starts
- 2025-01-31
- Est. completion
- 2026-12
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Primary caregiver of a patient scheduled to receive CS+HIPEC at Atrium Health Wake Forest Baptist Comprehensive Cancer Center
- Access to a computer or smartphone and must have an email address
- 18 years of age or older at the time of consent
- The ability to understand and willingness to provide written informed consent
- The ability to read and write English
You can't join if
- Patient declines access to their medical record
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openWake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, United States
- Katie Duckworth, PhD · Principal investigator
Recruiting
Study team
Sponsor
Wake Forest University Health Sciences
Study ID IRB00110615
Principal investigator
Katie Duckworth
Wake Forest Baptist Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.